Intouch Sakpakdeejaroen

Dr. Intouch Sakpakdeejaroen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in The Scientific World Journal
Verified
Journal Article
Open access
PDF file
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen
PMPatcharaporn Muanrit
Patcharaporn Muanrit
SPSumalee Panthong
Sumalee Panthong
SRSrisopa Ruangnoo
Srisopa Ruangnoo
Alpha-mangostin, a natural xanthone mainly extracted from the pericarp of Garcinia mangostana, has been shown to have promising anticancer properties in many types of cancer. However, the therapeutic potential of α-mangostin has been limited so far due to its poor aqueous solubility and low oral bioavailability, which limited its biopharmaceutical applications. Furthermore, α-mangostin failed to specifically reach tumors at a therapeutic concentration due and rapid elimination in vivo. We hypothesized that this drawback could be overcome by loading the drug within a delivery system conjugated to transferrin (Tf), whose receptors are overexpressed on many cancer cells and would enhance the specific delivery of α-mangostin to cancer cells, thereby enhancing its therapeutic efficacy. The objectives of this study were therefore to prepare and characterize transferrin-conjugated lipid-polymer hybrid nanoparticles (LPHN) entrapping α-mangostin, as well as to evaluate their therapeutic efficacy in vitro. We successfully prepared α-mangostin loaded LPHN using a one-step nanoprecipitation method with high drug entrapment efficiency. The conjugation of Tf to the LPHN was achieved by using the thiolmaleimide click reaction, leading to an increase in the particle hydrodynamic size of Tf-LPHN compared to that of unconjugated (control) LPHN (Ctrl-LPHN). Both Tf-LPHN and Ctrl-LPHN were bearing negative surface charges. Tf-LPHN and Ctrl-LPHN exhibited a sustained release of α-mangostin at pH 7.4, following an initial burst release, unlike rapid release of drug solution. The entrapment of α-mangostin in the LPHN led to an increase in α-mangostin uptake by cancer cells, and thus improved its antiproliferative activity compared to that observed with the drug solution. In conclusion, α-mangostin entrapped in the Tf-LPHN is therefore a highly promising therapeutic system that should be further optimized as therapeutic tools for cancer treatment.

20 November 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
KMKhadeejah Maeyouf
Khadeejah Maeyouf
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen
SSSukrut Somani
Sukrut Somani
JMJitkasem Meewan
Jitkasem Meewan
HAHawraa Ali-Jerman
Hawraa Ali-Jerman
Christine DufèsChristine Dufès
Christine Dufès
Gene therapy holds great promise for treating prostate cancer unresponsive to conventional therapies. However, the lack of delivery systems that can transport therapeutic DNA and drugs while targeting tumors without harming healthy tissues presents a significant challenge. This study aimed to explore the potential of novel hybrid lipid nanoparticles, composed of biocompatible zein and conjugated to the cancer-targeting ligand transferrin. These nanoparticles were designed to entrap the anti-cancer drug docetaxel and carry plasmid DNA, with the objective of improving the delivery of therapeutic payloads to prostate cancer cells, thereby enhancing their anti-proliferative efficacy and gene expression levels. These transferrin-bearing, zein-based hybrid lipid nanoparticles efficiently entrapped docetaxel, leading to increased uptake by PC-3 and LNCaP cancer cells and significantly enhancing anti-proliferative efficacy at docetaxel concentrations exceeding 1 µg/mL. Furthermore, they demonstrated proficient DNA condensation, exceeding 80% at polymer–DNA weight ratios of 1500:1 and 2000:1. This resulted in increased gene expression across all tested cell lines, with the highest transfection levels up to 11-fold higher than those observed with controls, in LNCaP cells. These novel transferrin-bearing, zein-based hybrid lipid nanoparticles therefore exhibit promising potential as drug and gene delivery systems for prostate cancer therapy.

13 January 2025 in Talanta Open
Verified
Journal Article
Open access
PMPatcharaporn Muanrit
Patcharaporn Muanrit
SPSaovapak Poomirat
Saovapak Poomirat
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen

25 May 2025 in Integrative Medicine Research
Verified
Journal Article
Open access
JJJaiboonya Jaicharoensub
Jaiboonya Jaicharoensub
SPSumalee Panthong
Sumalee Panthong
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen
TEThanee Eiamsitrakoon
Thanee Eiamsitrakoon
PBPatommatat Bhanthumkomol
Patommatat Bhanthumkomol
Foodborne illness (FI) causes 600 million cases and 420,000 deaths annually. Current treatments focus on rehydration and antispasmodic medications for managing dehydration and abdominal pain (AP). However, alternative therapies, especially those derived from natural ingredients, are needed. This study investigates the potential efficacy of herbal medicine,Thatbunjob as a complementary therapy for FI-related AP. A double-blind, randomized, placebo-controlled clinical trial assessed the efficacy of Thatbunjob in relieving AP in FI patients. A total of 114 patients, aged 18–60, with AP and diarrhea (≥3 episodes in 24 h), received either two 500 mg capsules of Thatbunjob or a placebo three times daily for three days. Both groups also received standard oral rehydration therapy. Primary outcomes included AP intensity using a visual analog scale (VAS) at 24 h, while secondary outcomes included pain at 48 and 72 h, responder rates, hyoscine butyl bromide usage, stool frequency, and adverse events. The Thatbunjob group showed significantly greater reduction in AP compared to the placebo. VAS scores decreased from 5.69 to 2.95 at 24 h (P < 0.001), and pain relief persisted at 48 (1.43 vs. 3.05, P < 0.001) and 72 h (0.32 vs. 1.86, P < 0.001). Thatbunjob also reduced the need for hyoscine tablets and decreased stool frequency compared to placebo. This study demonstrates that Thatbunjob, when combined with standard rehydration therapy, effectively alleviates AP and reduces stool frequency in FI patients. Thai Clinical Trials Registry, TCTR20220823001.

24 April 2024 in Asian Medical Journal and Alternative Medicine
Verified
Journal Article
Open access
PDF file
ATAtchanika Taingthum
Atchanika Taingthum
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen
SPSumalee Panthong
Sumalee Panthong
PKPuritat Kanokkangsadal
Puritat Kanokkangsadal
Introduction: Psoriasis is an immune-mediated inflammatory skin disease. The pathogenesis of psoriasis has been associated with an increase of oxidative stress. Therefore, natural antioxidant compounds (e.g., phenolics and flavonoids) might be beneficially used as an adjuvant. Ruean-Khi-Nok (RKN) remedy is a Thai traditional preparation used to treat psoriatic skin, consisting of nine plants in an equal proportion. Objectives: To investigate the antioxidant capability of the RKN remedy and its components using three chemical-based assays, as well as to determine phenolic and flavonoid contents.Methods: The 95% and 40% ethanolic extracts of RKN remedy and its plant components were investigated for in vitro antioxidant activities using DPPH and ABTS radical scavenging assay, as well as FRAP assay. The total phenolic and flavonoid contents in extracts were quantified using the Folin-Ciocalteu’s method and the aluminum chloride colorimetric method, respectively.Results: The results exhibited potential antioxidant activity of the 95% ethanolic extract of RNK remedy in the DPPH, ABTS and FRAP assay. In addition, it also contained high phenolic and flavonoid contents. Among individual plants, Piper wallichii extracts displayed outstanding antioxidant capability compared to the others.Conclusions: The RKN remedy is therefore highly promising antioxidant and might support the traditional use of RKN remedy for treatment of psoriatic skin. However, RKN should be investigated further for psoriasis treatment.

1 January 2025 in The Scientific World Journal
Verified
Journal Article
Open access
TKThanakan Kitnithiprapha
Thanakan Kitnithiprapha
SPSumalee Panthong
Sumalee Panthong
ISIntouch Sakpakdeejaroen
Intouch Sakpakdeejaroen
SKSumalee Kondo
Sumalee Kondo
Pathogens contaminate drinking water in tropical countries causing diarrheal diseases. The conventional treatment for diarrhea is antibiotics. However, overuse and misuse of antibiotics has enabled pathogens to adapt, causing global antibiotic resistance and proliferation of extended‐spectrum ß‐lactamase‐producing Escherichia coli (ESBL‐ E. coli ), which causes diarrhea and high levels of inflammatory cytokines. Apo‐taat, consisting of equal proportions of Phyllanthus emblica and Caesalpinia sappan , has been used to treat diarrhea and bloody diarrhea. Its antibacterial activity against E. coli ATCC 25922 has been reported, but its inhibitory effect against ESBL‐ E. coli has yet to be documented. This study investigated the antibacterial effect of Apo‐taat extract against ESBL‐ E. coli and its anti‐inflammatory activity. Antibacterial activity was determined by the microtiter plate–based method. HPLC was used to determine the brazilin and gallic acid contents in Apo‐taat extract. Effects of herbal extracts on nitric oxide, IL‐6, and TNF‐α were investigated in RAW 264.7 cells. Results were that Apo‐taat extract showed MIC values against ESBL‐ E. coli in the range of 0.625 to 2.5 mg/mL. Its 50% inhibitory concentration against nitric oxide and IL‐6 production was 83.96 ± 10.60 and 83.06 ± 2.07 μg/mL, respectively, and it had slight inhibition against TNF‐α. These findings suggest that Apo‐taat may have an antibacterial impact on ESBL‐ E. coli and anti‐inflammatory activity. Furthermore, safety and clinical trials should be conducted in the future.